No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Celcuity (CELC)
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $27 to $42
Celcuity Price Target Maintained With a $27.00/Share by HC Wainwright & Co.
Celcuity Down Over 12%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk
Celcuity Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.
Stifel Nicolaus Remains a Buy on Celcuity (CELC)
No Data
No Data